Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 45

Daily Deal Round Up: May 4, 2021

Solidia Technologies, Kelun Biotech and Doer Biologics all raised more than $70m while Sony added cash to a round valuing Discord at $7bn.

May 4, 2021

Roivant engineers $7.3bn reverse takeover

Dexxon, SoftBank and Sumitomo Dainippon-backed medical company builder Roivant Sciences will get a public listing through the transaction.

May 4, 2021

Sonder sends out $2.2bn reverse merger plans

The Lennar-backed accommodation provider will take a Nasdaq listing having previously raised $530m, and was valued at $1.3bn as of June 2020.

May 4, 2021

Mobvista wins Reyun in $232m deal

Fosun is set to exit the mobile data-monitoring platform developer in an acqusition by Mobvista that will follow $36m of funding.

May 4, 2021

Daily Deal Round Up: April 30, 2021

Driverless vehicle developer EasyMile closed a $66.4m round featuring Alstom and Continental while UCB and LivaNova-backed EEG technology developer Ceribell secured $53m.

Apr 30, 2021

Tata gets assent for BigBasket majority purchase

Alibaba could potentially sell $550m of shares in the deal, which has been given approval by regulators and which will give Tata a 64% stake in return for $1.2bn.

Apr 30, 2021

Daily Deal Round Up: April 29, 2021

Rakuten took part in a $37m round for virtual kitchen operator Taster while Nano Dimension is buying M12-backed 3D microprinter developer NanoFabrica for up to $54.9m.

Apr 29, 2021

MessageBird's series C mushrooms to $1bn

Bonnier was among the investors that added $800m to the marketing technology provider's latest round, with $600m funding its purchase of SparkPost.

Apr 29, 2021

Shapeways crystallises reverse merger details

Desktop Metal is backing a $75m PIPE supporting the reverse takeover, which values the additive manufacturing technology provider at $410m.

Apr 29, 2021

Pfizer finds cash for Amplyx acquisition

Fungal infection treatment developer Amplyx Pharmaceuticals had disclosed $142m in funding from investors including Pfizer and Lundbeckfonden Ventures.

Apr 29, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here